Hugel Reports Impressive Growth with Q3 Net Sales of KRW 105.9 Billion Hugel Inc. demonstrates exceptional performance, achieving KRW 105.9 billion in net sales in Q3 2025, driven by global demand for its products.

Hugel Reports Impressive Growth with Q3 Net Sales of KRW 105.9 Billion #South_Korea #Seoul #Hugel #Letybo #Revolax

Hugel Celebrates 15 Years of Letybo with Global H.E.L.F. Symposium in Seoul The H.E.L.F. symposium hosted by Hugel marked the 15th anniversary of Letybo, focusing on Korean beauty standards and aesthetics with global participation.

Hugel Celebrates 15 Years of Letybo with Global H.E.L.F. Symposium in Seoul #South_Korea #Seoul #Hugel #K-Beauty #Letybo

Hugel Inc. Unveils Letybo: A New Era for Aesthetic Medicine in Malaysia Hugel Inc. announces the launch of its botulinum toxin product Letybo in Malaysia, marking a significant step in the aesthetic market through collaboration with Venusys Medical.

Hugel Inc. Unveils Letybo: A New Era for Aesthetic Medicine in Malaysia #Hugel #Malaysia #Letybo #Venusys_Medical #Kuantan